NCT05486481 2025-03-06
Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)
University of California, San Francisco
Phase 1/2 Withdrawn
Clinical Trials
1 trialsPhase 1/2 × Immunoglobulin Light-chain Amyloidosis × In Situ Hybridization, Fluorescence × Clear all